These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 10692608)

  • 61. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections.
    Sharma P; Czyz CN; Wulc AE
    Aesthet Surg J; 2011 Nov; 31(8):966-71. PubMed ID: 22001341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Botulinum toxin for the treatment of musculoskeletal pain and spasm.
    Sheean G
    Curr Pain Headache Rep; 2002 Dec; 6(6):460-9. PubMed ID: 12413405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.
    Yoon SJ; Ho J; Kang HY; Lee SH; Kim KI; Shin WG; Oh JM
    Pharmacotherapy; 2007 May; 27(5):657-65. PubMed ID: 17461700
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study.
    Ketenci A; Basat H; Esmaeilzadeh S
    Agri; 2009 Jul; 21(3):95-103. PubMed ID: 19780000
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
    Dessie SG; Von Bargen E; Hacker MR; Haviland MJ; Elkadry E
    Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
    Lowe PL; Lowe NJ
    Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treating severe bruxism with botulinum toxin.
    Tan EK; Jankovic J
    J Am Dent Assoc; 2000 Feb; 131(2):211-6. PubMed ID: 10680389
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Botulinum toxin A injection in the treatment of hemifacial spasm.
    Chen RS; Lu CS; Tsai CH
    Acta Neurol Scand; 1996 Sep; 94(3):207-11. PubMed ID: 8899054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of acute dysmenorrhoea and pelvic pain syndrome of uterine origin with myometrial botulinum toxin injections under hysteroscopy: A pilot study.
    Bautrant E; Franké O; Amiel C; Bensousan T; Thiers-Bautrant D; Levêque C
    J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101972. PubMed ID: 33186771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Accuracy of botulinum toxin injections in myofascial pain. Response to Gobel et al. Pain 2006;125:82-8.
    Reilich P; Schoser BGH
    Pain; 2007 Aug; 130(3):299. PubMed ID: 17532140
    [No Abstract]   [Full Text] [Related]  

  • 77. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL; Gray DS; Burnham RS
    Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.
    Park H; Shin S; Shin HS; Kim HW; Kim DW; Lee DH
    Clin Orthop Relat Res; 2016 Dec; 474(12):2705-2711. PubMed ID: 27506971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.